Abedon S., Kuhl S., Blasdel B., Kutter E. (2011). Phage treatment of human infections. Bacteriophage 1, 66–85 10.4161/bact.1.2.15845 -DOI -PMC -PubMed
Biswas B., Adhya S., Washart P., Paul B., Trostel A., Powell B., Carlton R., Merril C. (2002). Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70, 204–210 10.1128/IAI.70.1.204-210.2002 -DOI -PMC -PubMed
Bruttin A., Brussow H. (2005). Human volunteers receiving Escherischia coli phage T4 orally: a safety test of phage therapy. Antimicrob. Agents Chemother. 49, 2874–2878 10.1128/AAC.49.7.2874-2878.2005 -DOI -PMC -PubMed
Buffie C., Jarchum I., Equinda M., Lipuma L., Gobourne A., Viale A., Ubeda-Morant C., Xavier J., Pamer E. (2011). Profound alterations of intestinal microbiata following a single dose of clindamycin results in sustained susceptibility to _Clostridium difficile_-induced colitis. Infect. Immun. 80, 62–73 10.1128/IAI.05496-11 -DOI -PMC -PubMed
Bull J., Levin B., DeRouin T., Walker N., Bloch C. (2002). Dynamics of success and failure in phage and antibiotic therapy in experimental infections. BMC Microbiol. 2, 35. 10.1186/1471-2180-2-35 -DOI -PMC -PubMed